Skip to content
← Back to this collection

PUBLICATIONS · 33539729

4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Mar
First author
Hoskin P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hoskin P
      type
      Author
    2. name
      Popova B
      type
      Author
    3. name
      Schofield O
      type
      Author
    4. name
      Brammer C
      type
      Author
    5. name
      Robinson M
      type
      Author
    6. name
      Brunt AM
      type
      Author
    7. name
      Madhavan K
      type
      Author
    8. name
      Illidge T
      type
      Author
    9. name
      Gallop-Evans E
      type
      Author
    10. name
      Syndikus I
      type
      Author
    11. name
      Clifton-Hadley L
      type
      Author
    12. name
      Kirkwood AA
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hoskin P
      type
      Author
    2. name
      Popova B
      type
      Author
    3. name
      Schofield O
      type
      Author
    4. name
      Brammer C
      type
      Author
    5. name
      Robinson M
      type
      Author
    6. name
      Brunt AM
      type
      Author
    7. name
      Madhavan K
      type
      Author
    8. name
      Illidge T
      type
      Author
    9. name
      Gallop-Evans E
      type
      Author
    10. name
      Syndikus I
      type
      Author
    11. name
      Clifton-Hadley L
      type
      Author
    12. name
      Kirkwood AA
      type
      Author
    bibliography ids
    1. nci-bib-6c09447cd91ee5a190f148b8
    book metadata
    content sha256
    059de56fe8265d40cf30e58f31072e359eda54888ba157c41d562fe43d2f9dc4
    document type
    citation
    dois
    1. 10.1016/S1470-2045(20)30686-0
    electronic publication date
    display
    2021 Feb 1
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:33539729
    immutable id
    pubmed:33539729@059de56fe8265d40cf30e58f31072e359eda54888ba157c41d562fe43d2f9dc4
    journal
    abbreviation
    Lancet Oncol
    issn electronic
    1474-5488
    issn print
    1470-2045
    issue
    3
    name
    The Lancet. Oncology
    nlm unique id
    100957246
    pages
    332-340
    volume
    22
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      33539729
      provenance
      batch id
      79f1021053e858d13ff3
      provider
      NCBI PubMed ESummary
      record sha256
      598ed206b808defe6b2041ee6fd9f98d3189791eae84e5dd71f7ac944f345852
      response sha256
      671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
      retrieved at
      2026-09-09T23:47:59.098265+00:00
      publication date
      display
      2021 Mar
      precision
      month
      year
      2021
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Multicenter Study
      5. Randomized Controlled Trial
      6. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/33539729/
      title
      4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial.

      Preserved source evidence · Independent clinical review pending · Not medical advice